Literature DB >> 23615977

Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells.

Rachel M Hagen1, Veronica S Chedea, Christopher P Mintoff, Elizabeth Bowler, H Ruth Morse, Michael R Ladomery.   

Abstract

Growing evidence suggests that the flavonoid epigallocatechin-3-gallate (EGCG), notably abundant in green tea, has health-promoting properties. We examined the effect of EGCG on cell survival and apoptosis in the prostate cancer cell line PC3. Cell survival was reduced and apoptosis increased significantly with a low dose of 1 µM EGCG. The ability of the anticancer drug cisplatin to promote apoptosis was enhanced by EGCG. Furthermore, EGCG, both alone and in combination with cisplatin, promoted the expression of the pro-apoptotic splice isoform of caspase 9.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23615977     DOI: 10.3892/ijo.2013.1920

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  13 in total

1.  The Green Tea Component (-)-Epigallocatechin-3-Gallate Sensitizes Primary Endothelial Cells to Arsenite-Induced Apoptosis by Decreasing c-Jun N-Terminal Kinase-Mediated Catalase Activity.

Authors:  Jee-Youn Kim; Ji-Young Choi; Hyeon-Ju Lee; Catherine Jeonghae Byun; Jung-Hyun Park; Jae Hoon Park; Ho-Seong Cho; Sung-Jin Cho; Sangmee Ahn Jo; Inho Jo
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

2.  The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.

Authors:  Christian Mayr; Andrej Wagner; Daniel Neureiter; Martin Pichler; Martin Jakab; Romana Illig; Frieder Berr; Tobias Kiesslich
Journal:  BMC Complement Altern Med       Date:  2015-06-23       Impact factor: 3.659

3.  Enhancement of Cisplatin sensitivity in human cervical cancer: epigallocatechin-3-gallate.

Authors:  Ulkan Kilic; Kazim Sahin; Mehmet Tuzcu; Nazli Basak; Cemal Orhan; Birsen Elibol-Can; Ertugrul Kilic; Fikrettin Sahin; Omer Kucuk
Journal:  Front Nutr       Date:  2015-01-26

4.  EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer.

Authors:  Xuemin Wang; Pan Jiang; Pengqi Wang; Chung S Yang; Xuerong Wang; Qing Feng
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

Review 5.  Dietary polyphenols in prevention and treatment of prostate cancer.

Authors:  Rahul K Lall; Deeba N Syed; Vaqar M Adhami; Mohammad Imran Khan; Hasan Mukhtar
Journal:  Int J Mol Sci       Date:  2015-02-03       Impact factor: 5.923

Review 6.  Date (Phoenix dactylifera) Polyphenolics and Other Bioactive Compounds: A Traditional Islamic Remedy's Potential in Prevention of Cell Damage, Cancer Therapeutics and Beyond.

Authors:  Bibi R Yasin; Hassan A N El-Fawal; Shaker A Mousa
Journal:  Int J Mol Sci       Date:  2015-12-17       Impact factor: 5.923

7.  Actein induces autophagy and apoptosis in human bladder cancer by potentiating ROS/JNK and inhibiting AKT pathways.

Authors:  Lu Ji; Bing Zhong; Xi Jiang; Fei Mao; Gang Liu; Bin Song; Cheng-Yuan Wang; Yong Jiao; Jiang-Ping Wang; Zhi-Bin Xu; Xing Li; Bo Zhan
Journal:  Oncotarget       Date:  2017-11-01

Review 8.  Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention.

Authors:  Simona Izzo; Valeria Naponelli; Saverio Bettuzzi
Journal:  Nutrients       Date:  2020-04-06       Impact factor: 5.717

Review 9.  Prooxidant Effects of Epigallocatechin-3-Gallate in Health Benefits and Potential Adverse Effect.

Authors:  Jie Ouyang; Kun Zhu; Zhonghua Liu; Jianan Huang
Journal:  Oxid Med Cell Longev       Date:  2020-08-12       Impact factor: 6.543

Review 10.  Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets.

Authors:  Fabrizio Fontana; Michela Raimondi; Monica Marzagalli; Alessandro Di Domizio; Patrizia Limonta
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.